Bharat Parenterals Board Meeting for Q2 FY27 Results

The primary agenda items for the board meeting include:

• Consideration and approval of the Unaudited Standalone Financial Results for the quarter and half year ended September 30, 2026
• Consideration and approval of the Unaudited Consolidated Financial Results for the quarter and half year ended September 30, 2026
• Taking on record the aforementioned financial results
• Consideration of any other business with the permission of the Chair

Trading Window Closure

In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their immediate relatives, the trading window for dealing in the company's securities has been closed for all designated persons. The closure period began on Thursday, October 1, 2026 and will remain in effect until forty-eight (48) hours after the declaration of the financial results.

Additional Information

The notice is available on the company's website at www.bplindia.in. The disclosure was signed by Mr. Sharmin Soni, Company Secretary & Compliance Officer (ICSI Membership No: A-75694) from Vadodara.